Amarin (NASDAQ:AMRN) Now Covered by StockNews.com
StockNews.com assumed coverage on shares of Amarin (NASDAQ:AMRN – Free Report) in a report issued on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. AMRN has been the subject of a number of other research reports. Northland Securities reduced their price objective on Amarin from $2.00 to $1.25 in a report […]